Healthcare provider profile · identity verified

Edward D Reese, M.D.

Family Practice · DEXTER, MO · NPI 1013279918

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	377	82
Gabapentin	Gabapentin	312	75
Omeprazole	Omeprazole	251	63
Alprazolam	Alprazolam	249	36
Atorvastatin Calcium	Atorvastatin Calcium	246	71
Lisinopril	Lisinopril	228	64
Pantoprazole Sodium	Pantoprazole Sodium	227	62
Levothyroxine Sodium	Levothyroxine Sodium	199	64
Albuterol Sulfate Hfa	Albuterol Sulfate	195	52
Trazodone Hcl	Trazodone Hcl	174	46
Furosemide	Furosemide	156	47
Losartan Potassium	Losartan Potassium	154	49
Metoprolol Succinate	Metoprolol Succinate	135	45
Potassium Chloride	Potassium Chloride	135	36
Clopidogrel	Clopidogrel Bisulfate	130	37
Amlodipine Besylate	Amlodipine Besylate	129	41
Rosuvastatin Calcium	Rosuvastatin Calcium	122	32
Meloxicam	Meloxicam	118	42
Fluticasone Propionate	Fluticasone Propionate	117	46
Metformin Hcl Er	Metformin Hcl	116	40
Carvedilol	Carvedilol	115	29
Montelukast Sodium	Montelukast Sodium	114	32
Spironolactone	Spironolactone	113	21
Sertraline Hcl	Sertraline Hcl	106	23
Trulicity	Dulaglutide	102	25
Eliquis	Apixaban	97	16
Hydrochlorothiazide	Hydrochlorothiazide	97	27
Famotidine	Famotidine	96	23
Oxcarbazepine	Oxcarbazepine	90	22
Metoprolol Tartrate	Metoprolol Tartrate	89	23
Tamsulosin Hcl	Tamsulosin Hcl	89	24
Pregabalin	Pregabalin	87	19
Ropinirole Hcl	Ropinirole Hcl	87	28
Glipizide Er	Glipizide	86	29
Duloxetine Hcl	Duloxetine Hcl	84	20
Ondansetron Odt	Ondansetron	83	21
Prednisone	Prednisone	82	41
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	81	13
Celecoxib	Celecoxib	79	25
Tramadol Hcl	Tramadol Hcl	76	18
Topiramate	Topiramate	73	20
Tizanidine Hcl	Tizanidine Hcl	69	17
Clonazepam	Clonazepam	65	12
Lorazepam	Lorazepam	64	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	23
Metformin Hcl	Metformin Hcl	60	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	22
Symbicort	Budesonide/Formoterol Fumarate	58	16
Jardiance	Empagliflozin	57	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	55	16
Zolpidem Tartrate	Zolpidem Tartrate	55	11
Buspirone Hcl	Buspirone Hcl	53	11
Citalopram Hbr	Citalopram Hydrobromide	53	12
Januvia	Sitagliptin Phosphate	52	12
Ozempic	Semaglutide	50	15
Escitalopram Oxalate	Escitalopram Oxalate	49	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	44
Pravastatin Sodium	Pravastatin Sodium	44	14
Linzess	Linaclotide	43	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	42	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	41	12
Dicyclomine Hcl	Dicyclomine Hcl	41	12
Memantine Hcl	Memantine Hcl	41	suppressed
Bupropion Hcl Sr	Bupropion Hcl	39	12
Estradiol	Estradiol	38	suppressed
Bupropion Xl	Bupropion Hcl	36	suppressed
Fluconazole	Fluconazole	36	21
Oxybutynin Chloride Er	Oxybutynin Chloride	35	13
Simvastatin	Simvastatin	35	11
Testosterone Cypionate	Testosterone Cypionate	35	suppressed
Promethazine Hcl	Promethazine Hcl	34	suppressed
Cefdinir	Cefdinir	32	25
Azithromycin	Azithromycin	31	28
Combivent Respimat	Ipratropium/Albuterol Sulfate	31	suppressed
Mirtazapine	Mirtazapine	31	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Mupirocin	Mupirocin	30	18
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Colesevelam Hcl	Colesevelam Hcl	28	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Bumetanide	Bumetanide	26	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Methylprednisolone	Methylprednisolone	26	23
Torsemide	Torsemide	26	suppressed
Diazepam	Diazepam	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Repatha Sureclick	Evolocumab	25	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Varenicline Tartrate	Varenicline Tartrate	24	suppressed
Lamotrigine	Lamotrigine	23	suppressed
Loperamide	Loperamide Hcl	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Primidone	Primidone	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Cilostazol	Cilostazol	18	suppressed
Dexamethasone	Dexamethasone	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Lubiprostone	Lubiprostone	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Finasteride	Finasteride	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Naproxen	Naproxen	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Clonidine	Clonidine	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Levofloxacin	Levofloxacin	14	13
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	13
Flecainide Acetate	Flecainide Acetate	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Theophylline Er	Theophylline Anhydrous	13	suppressed
Allopurinol	Allopurinol	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Atenolol	Atenolol	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Modafinil	Modafinil	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Temazepam	Temazepam	11	suppressed
Trulance	Plecanatide	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error